OJMM  Vol.3 No.1 , March 2013
Analysis of Enterobacteriaceae Producing Broad-Spectrum Beta-Lactamases in the Intensive Care Unit Setting
ABSTRACT
Strains of the Enterobacteriaceae family producing ESBL and AmpC broad-spectrum beta-lactamases that may survive in the hospital setting potentially cause infection in hospitalized patients due to contaminated objects or health care workers’ hands. Over a period of two months (November-December 2010), a single epidemiological study of microbial contamination of air, surfaces and health care workers (swabs from both nostrils and the right hand without a glove) was carried out at two intensive care units of the University Hospital Olomouc, Czech Republic. The bacteria were identified using standard microbiological methods. Phenotypic detection of ESBL and AmpC enzymes and basic genetic analysis of ESBL- and AmpC-positive isolates was performed. The same approach was used to identify and analyze bacteria isolated from clinical samples of patients hospitalized at the above departments over the study period. From a total of 140 environmental samples collected over the study period, 21 isolates of the Enterobacteriaceae family were identified, with ESBL and AmpC production being detected in 4 and 7 isolates, respectively. Among patients’ clinical samples, 10 ESBL- and 6 AmpC-positive isolates were detected. No similarity was found between environmental isolates and strains isolated from patients.

Cite this paper
V. Husičková, M. Htoutou-Sedláková, I. Matoušková, M. Chromá and M. Kolář, "Analysis of Enterobacteriaceae Producing Broad-Spectrum Beta-Lactamases in the Intensive Care Unit Setting," Open Journal of Medical Microbiology, Vol. 3 No. 1, 2013, pp. 56-61. doi: 10.4236/ojmm.2013.31009.
References
[1]   C. M. Luna, P. Vujacich, M. S. Niederman, C. Vay, C. Gherardi, J. Matera and E. C. Jolly, “Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated Pneumonia,” Chest, Vol. 111, No. 3, 1997, pp. 676-685. doi:10.1378/chest.111.3.676

[2]   M. Tumbarello, M. Sanguinetti, E. Montuori, E. M. Trecarichi, B. Posteraro, B. Fiori, R. Citton, T. D’Inzeo, G. Fadda, R. Cauda and T. Spanu, “Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-?-Lactamase-Producing Enterobacteriaceae: Importance of Inadequate Initial Antimicrobial Treatment,” Antimicrobial Agents and Chemotherapy, Vol. 51, No. 6, 2007, pp. 1987-1994. doi:10.1128/AAC.01509-06

[3]   S. Müller, A. Oesterlein, M. Frosh, M. Abele-Horn and G. Valenza, “Characterization of Extended-Spectrum BetaLactamases and qnr Plasmid-Mediated Quinolone Resistance in German Isolates of Enterobacter Species,” Microbial Drug Resistance, Vol. 17, No. 1, 2011, pp. 99-103. doi:10.1089/mdr.2010.0114

[4]   C. H. Lee, J. W. Liu, C. C. Li, C. C. Chien, Y. F. Tang and L. H. Su, “Spread of ISCR1 Elements Containing blaDHA-1 and Multiple Antimicrobial Resistance Genes Leading to Increase of Flomoxef Resistance in ExtendedSpectrum-β-Lactamase-Producing Klebsiella pneumoniae,” Antimicrobial Agents and Chemotherapy, Vol. 55, No. 9, 2011, pp. 4058-4063. doi:10.1128/AAC.00259-11

[5]   A. Sattar, F. Faqir, S. A. Abbasi, A. Fraz and Z. Hussain, “Changing Trends in Frequency of Extended-Spectrum Beta-Lactamase Producing Gram Negative Bacilli in Intensive Care Units of a Tertiary Care Hospital,” Pakistan Armed Forces Medical Journal, Vol. 59, No. 3, 2009, pp. 271-274.

[6]   M. H. Sedlakova, V. Hanulik, M. Chroma, K. Hricova, M. Kolar, T. Latal, R. Schaumann and A. C. Rodloff, “Phenotypic Detection of Broad-Spectrum Beta-Lactamases in Microbiological Practice,” Medical Science Monitor, Vol. 17, No. 5, 2011, pp. 147-152. doi:10.12659/MSM.881761

[7]   L. Cekanova, M. Kolar, M. Chroma, P. Sauer, M. Sedlácková and D. Koukalová, “Prevalence of ESBL-Positive Bacteria in the Community in the Czech Republic,” Medical Science Monitor, Vol. 15, No. 7, 2009, pp. 202206.

[8]   S. J. Dancer, “What’s under Your Bed?! ESBLs: Infection Control in the Hospital Environment,” SCIEH Weekly Report, Vol. 38, No. 50, 2004.

[9]   D. Pittet, B. Allegranzi, H. Sax, S. Dharan, C. L. PessoaSilva, L. Donaldson, J. M. Boyce, WHO Global Patient Safety Challenge and World Alliance for Patient Safety, “Evidence-Based Model for Hand Transmission during Patient Care and the Role of Improved Practices,” The Lancet Infectious Diseases, Vol. 6, No. 10, 2006, pp. 641-652. doi:10.1016/S1473-3099(06)70600-4

[10]   A. Noy, R. Orni-Wasserlauf, P. Sorkine and Y. SiegmanIgra, “Epidemiology of Ceftazidime-Resistant Klebsiella pneumoniae in a Large University Hospital in Tel Aviv,” The Israel Medical Association Journal, Vol. 2, No. 12, 2000, pp. 908-911.

[11]   V. Jarlier, M. H. Nicolas, G. Fournier and A. Philippon, “Extended Broad-Spectrum ?-Lactamases Conferring Transferable Resistance to Newer ?-Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility Patterns,” Clinical Infectious Diseases, Vol. 10, No. 4, 1988, pp. 867-878. doi:10.1093/clinids/10.4.867

[12]   M. Kolá?, “Clinical Significance of Broad-Spectrum ?Lactamases and Experience with Their Identification in Microbiological Practice,” Klinická Mikrobiologie a Infek?ní Léka?ství, Vol. 13, No. 5, 2007, pp. 195-205.

[13]   T. Yagi, J. Wachino, H. Kurokawa, S. Suzuki, K. Yamane, Y. Doi, N. Shibata, H. Kato, K. Shibayama and Y. Arakawa, “Practical Methods Using Boronic Acid Compounds for Identification of Class C β-LactamaseProducing Klebsiella pneumoniae and Eschericha coli,” Journal of Clinical Microbiology, Vol. 43, No. 6, 2005, pp. 2551-2558. doi:10.1128/JCM.43.6.2551-2558.2005

[14]   M. H. Sedlakova, V. Hanulik, M. Chroma, K. Hricova, M. Kolar, R. Schaumann and A. C. Rodloff, “The Potential of Phenotypic Methods for Detecting ESBLand AmpCType Broad-Spectrum Beta-Lactamases,” Clinical Microbiology and Infection, Vol. 16, No. 2, 2010, p. S152.

[15]   M. Kolar, J. Bardon, M. Chroma, K. Hricova, T. Stosova, P. Sauer and D. Koukalova, “ESBL and AmpC BetaLactamase-Producing Enterobacteriaceae in Poultry in the Czech Republic,” Veterinary Medicine, Vol. 55, No. 3, 2010, pp. 119-124.

[16]   A. Chanawong, F. H. M’Zali, J. Heritage, A. Lulitanond and P. M. Hawkey, “Characterisation of Extended-Spectrum β-Lactamases of the SHV Family Using a Combination of PCR-Single Strand Conformational Polymorphism (PCR-SSCP) and PCR-Restriction Fragment Length Polymorphism (PCR-RFLP),” FEMS Microbiology Letters, Vol. 184, No. 1, 2000, pp. 85-89.

[17]   G. Arlet, G. Brami, D. Décrè, A. Flippo, O. Gaillot, P. H. Lagrange and A. Philippon, “Molecular Characterisation by PCR-Restriction Fragment Length Polymorphism of TEM β-Lactamases,” FEMS Microbiology Letters, Vol. 134, No. 2-3, 1995, pp. 203-208.

[18]   M. Pimkin and M. Edelstein, “Improved PCR Detection and Subtyping of CTX-M β-Lactamase-Encoding Genes,” 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, 1-4 May 2004.

[19]   Z. Y. Shi, P. Y. Liu, Y. J. Lau, Y. H. Lin and B. S. Hu, “Epidemiological Typing of Isolates from an Outbreak of Infection with Multidrug-Resistant Enterobacter cloacae by Repetitive Extragenic Palindromic Unit b1-Primed PCR and Pulsed-Field Gel Electrophoresis,” Journal of Clinical Microbiology, Vol. 34, No. 11, 1996, pp. 2784-2790.

[20]   P. Toltzis, T. Yamashita, L. Vilt, M. Green, A. Morrissey, S. Spinner-Block and J. Blumer, “Antibiotic Restriction Does Not Alter Endemic Colonization with Resistant Gram-Negative Rods in a Pediatric Intensive Care Unit,” Critical Care Medicine, Vol. 26, No. 11, 1998, pp. 1893-1899. doi:10.1097/00003246-199811000-00035

[21]   S. J. Dancer, L. F. White, J. Lamb, E. K. Girvan and C. Robertson, “Measuring the Effect of Enhanced Cleaning in a UK Hospital: A Prospective Cross-Over Study,” BMC Medicine, Vol. 7, 2009, p. 28. doi:10.1186/1741-7015-7-28

[22]   D. L. Paterson, W. C. Ko, A. von Gottberg, S. Mohapatra, J. M. Casellas, H. Goossens, L. Mulazimoglu, G. Trenholme, K. P. Klugman, R. A. Bonomo, L. B. Rice, M. M. Wagener, J. G. McCormack and V. L. Yu, “International Prospective Study of Klebsiella pneumoniae Bacteraemia; Implications of Extended-Spectrum ?-Lactamase Production in Nosocomial Infections,” Annals of Internal Medicine, Vol. 140, No. 1, 2004, pp. 26-32.

[23]   D. L. Paterson, N. Singh, J. D. Rihs, C. Squier, B. L. Rihs and R. R. Muder, “Control of an Outbreak of Infection Due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in a Liver Transplantation Unit,” Clinical Infectious Diseases, Vol. 33, No. 1, 2001, pp. 126-128. doi:10.1086/320882

 
 
Top